Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kathayani Sudha"'
Autor:
Funda Korkmaz, Tan-Chun Kuo, Sakshi Gera, Damini Sant, Victoria DeMambro, Anisa Gumerova, Kathayani Sudha, Ashley Padilla, Jessica Netto, Farhath Sultana, Sari Miyashita, Eleanor Shelly, Pushkar Kumar, Jocoll Burgess, Hasni Kannangara, Valeriia Muradova, Susan Hutchison, Mansi Saxena, Vitaly Ryu, Se-Min Kim, Marcia Meseck, Ki Goosens, Cliff Rosen, Daria Lizneva, Tony Yuen, Mone Zaidi
Publikováno v:
Journal of the Endocrine Society. 6:A883-A884
Pharmacological and genetic studies over the past decade suggest that FSH is an actionable target for diseases affecting millions, notably osteoporosis, obesity and Alzheimer's disease (AD). Blocking FSH action prevents bone loss (1, 2), fat and ener
Autor:
Sakshi Gera, Tan-Chun Kuo, Funda Korkmaz, Damini Sant, Victoria DeMambro, Anisa Gumerova, Kathayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy van Leent, Tomas G.J.M. Post, Jessica C. Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Babunovic, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I. New, Vitaly Ryu, Se-Min Kim, Jay J. Cao, Neeha Zaidi, Zahi Fayad, Daria Lizneva, Clifford J. Rosen, Tony Yuen, Mone Zaidi
Pharmacological and genetic studies over the past decade have established FSH as an actionable target for diseases affecting millions, notably osteoporosis, obesity and Alzheimer’s disease (AD). Blocking FSH action prevents bone loss, fat gain and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6c2ddac0b44f0faf9f6545b16268fa4
https://doi.org/10.1101/2022.02.28.482279
https://doi.org/10.1101/2022.02.28.482279